New-onset atrial fibrillation detected by ambulatory ECG monitoring after transcatheter aortic valve implantation.
Jorge NucheFady SolimanJorge ChavarríaAlexis K OkohHugo Alvarado MoraIsabelle NaultMadhu K NatarajanMark RussoFrançois PhilipponJosep Rodés-CabauPublished in: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology (2024)
NOAF detected with AECG occurred in 7% of TAVI recipients and was associated with a higher AS severity. NOAF detection determined the start of anticoagulation therapy in about half of the patients, and it was not associated with an increased risk of clinical events at 1-year follow-up.
Keyphrases
- transcatheter aortic valve implantation
- atrial fibrillation
- aortic stenosis
- ejection fraction
- aortic valve
- aortic valve replacement
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- blood pressure
- transcatheter aortic valve replacement
- heart failure
- prognostic factors
- venous thromboembolism
- left atrial
- stem cells
- oral anticoagulants
- heart rate
- patient reported outcomes
- mesenchymal stem cells
- left atrial appendage
- percutaneous coronary intervention
- coronary artery disease
- cell therapy
- acute coronary syndrome
- direct oral anticoagulants
- kidney transplantation